TKI resistance in brain metastasis: A CTLA4 state of mind
- PMID: 39536715
- DOI: 10.1016/j.immuni.2024.10.009
TKI resistance in brain metastasis: A CTLA4 state of mind
Abstract
Resistance to tyrosine kinase inhibitors (TKIs) in lung cancer brain metastasis (LCBM) remains a clinical challenge. Recently in Cancer Cell, Fu et al. reveal how TKIs reshape the immune microenvironment of LCBM and propose CTLA4 blockade as a promising strategy to overcome resistance.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade.Cancer Cell. 2024 Nov 11;42(11):1882-1897.e7. doi: 10.1016/j.ccell.2024.09.012. Epub 2024 Oct 17. Cancer Cell. 2024. PMID: 39423817
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical